<DOC>
	<DOCNO>NCT00797810</DOCNO>
	<brief_summary>All patient treat accord therapy regimen . Therapy duration ( number cycle ) radiotherapy vary accord age group , stage response . Chemotherapy consist pre-phase-treatment ( patient ) vary A , B C cycle . Therapy Patients 18-55 Age Group - Patients stag III-IV patient mediastinal tumor extranodal involvement administer 6 cycle ( A1 , B1 , A2 , B2 , A3 , B3 ) . - Chemotherapy stop 4 cycle ( A1 , B1 , A2 , B2 ) patient stage I/ II clear CR achieve initially mediastinal extranodal involvement . - In case refractory progressive disease 4 cycle , study therapy stop . These patient give salvage therapy subsequent stem cell transplantation . Therapy Patients old 55 year - The course correspond patient young age group , regimen dose reduce ( A1* , B1* , A2* , B2* , A3* , B3* ) . Antibody therapy anti-CD20 administer day 1 chemotherapy cycle ( A , B ) . After end chemotherapy ( 6 4 cycle ) 2 cycle anti-CD 20 administer reach total number 8 resp . 6 cycle antibody therapy .</brief_summary>
	<brief_title>Intensification Therapy Mature B-ALL , Burkitt Burkitt Like Other High Grade Non-Hodgkin 's Lymphoma Adults</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Acute lymphoblastic leukemia mature Bcell type ( L3ALL ) Highgrade nonHodgkin 's lymphoma follow subtypes ( WHO classification ) Burkitt 's lymphoma ( include atypical Burkitt 's lymphoma ) Precursor Blymphoblastic lymphoma Anaplastic largecell lymphoma ( Ki1+ , B , T oder Nullcelltype ) Mediastinal large Bcelllymphoma ( subtype diffuse large Bcell lymphoma ) Age = 18 year Patient 's Informed Consent Serious complication cause leukemia/ lymphoma second illness : e.g . Severe , unmanageable complication sepsis , pneumonia oxygen deficiency , Shock , hemorrhage time diagnosis Renal insufficiency leukemia/lymphomaunrelated cause Severe cardiac hepatic insufficiency Severe obstructive restrictive lung disease would compromise patient 's treatment intensify chemotherapy HIV infection Secondary lymphoma follow prior chemotherapy/ radiotherapy active second malignancy Known severe allergy foreign proteins Cytostatic pretreatment BALL/lymphoma ( exception : shortterm administration steroid = 7 day , single administration vincristine cyclophosphamide , one cycle CHOP , single administration emergency cytostatic agent ) another malignant disease within last 5 year Pregnancy/ nursing period Severe psychiatric illness circumstance give ground assumption patient give consent therapy act cooperatively Absence patient 's informed consent Participation another clinical study would possibly interfere study therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Acute lymphoblastic leukemia mature B-cell type</keyword>
	<keyword>High-grade non-Hodgkin 's lymphoma</keyword>
</DOC>